GR3005934T3 - - Google Patents

Info

Publication number
GR3005934T3
GR3005934T3 GR920402254T GR920402254T GR3005934T3 GR 3005934 T3 GR3005934 T3 GR 3005934T3 GR 920402254 T GR920402254 T GR 920402254T GR 920402254 T GR920402254 T GR 920402254T GR 3005934 T3 GR3005934 T3 GR 3005934T3
Authority
GR
Greece
Application number
GR920402254T
Other languages
Greek (el)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of GR3005934T3 publication Critical patent/GR3005934T3/el

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D295/00Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D265/00Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D265/281,4-Oxazines; Hydrogenated 1,4-oxazines
    • C07D265/301,4-Oxazines; Hydrogenated 1,4-oxazines not condensed with other rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D267/00Heterocyclic compounds containing rings of more than six members having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D267/02Seven-membered rings
    • C07D267/08Seven-membered rings having the hetero atoms in positions 1 and 4
    • C07D267/10Seven-membered rings having the hetero atoms in positions 1 and 4 not condensed with other rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/06Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pyridine Compounds (AREA)
GR920402254T 1986-04-30 1992-10-12 GR3005934T3 (cg-RX-API-DMAC10.html)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP10155286 1986-04-30
JP31509086 1986-12-31

Publications (1)

Publication Number Publication Date
GR3005934T3 true GR3005934T3 (cg-RX-API-DMAC10.html) 1993-06-07

Family

ID=26442419

Family Applications (1)

Application Number Title Priority Date Filing Date
GR920402254T GR3005934T3 (cg-RX-API-DMAC10.html) 1986-04-30 1992-10-12

Country Status (18)

Country Link
US (1) US4870074A (cg-RX-API-DMAC10.html)
EP (1) EP0243959B1 (cg-RX-API-DMAC10.html)
KR (1) KR870010030A (cg-RX-API-DMAC10.html)
AR (1) AR242953A1 (cg-RX-API-DMAC10.html)
AU (1) AU592177B2 (cg-RX-API-DMAC10.html)
CA (1) CA1291135C (cg-RX-API-DMAC10.html)
CZ (1) CZ284687B6 (cg-RX-API-DMAC10.html)
DE (1) DE3781195T2 (cg-RX-API-DMAC10.html)
DK (1) DK175281B1 (cg-RX-API-DMAC10.html)
ES (1) ES2043617T3 (cg-RX-API-DMAC10.html)
FI (1) FI87776C (cg-RX-API-DMAC10.html)
GR (1) GR3005934T3 (cg-RX-API-DMAC10.html)
HK (1) HK18194A (cg-RX-API-DMAC10.html)
HU (1) HU198193B (cg-RX-API-DMAC10.html)
NZ (1) NZ220120A (cg-RX-API-DMAC10.html)
PH (1) PH24049A (cg-RX-API-DMAC10.html)
SK (1) SK289787A3 (cg-RX-API-DMAC10.html)
SU (1) SU1597101A3 (cg-RX-API-DMAC10.html)

Families Citing this family (40)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2640139A1 (fr) * 1988-12-14 1990-06-15 Delagrange Laboratoires Application de benzamides substitues comme gastromoteurs
US5395832A (en) * 1991-02-15 1995-03-07 Hokuriku Seiyaku Co., Ltd. Benzamide derivatives
TW213460B (cg-RX-API-DMAC10.html) * 1991-02-15 1993-09-21 Hokuriku Pharmaceutical
US5864039A (en) * 1994-03-30 1999-01-26 Yoshitomi Pharmaceutical Industries, Ltd. Benzoic acid compounds and use thereof as medicaments
EP0774460A1 (en) * 1994-03-30 1997-05-21 Yoshitomi Pharmaceutical Industries, Ltd. Benzoic acid compound and use thereof as medicine
NZ309065A (en) * 1995-05-23 1999-06-29 Janssen Pharmaceutica Nv (2-morpholinymethyl)benzamide derivatives having gastrointestinal motility stimulating properties
JP2001064177A (ja) * 1999-08-16 2001-03-13 Schering Ag ベンズアミド誘導体を有効成分とする製剤
BR0114323A (pt) 2000-09-29 2003-07-01 Glaxo Group Ltd Composto ou um seu sal ou solvato farmaceuticamente aceitável, composição farmacêutica, uso do composto ou de um seu sal ou solvato farmaceuticamente aceitável, método de tratamento ou profilaxia de doenças inflamatórias, e, processo para preparar o composto
EP1353918B1 (en) * 2000-11-28 2005-01-12 Smithkline Beecham Plc Morpholine derivatives as antagonists of orexin receptors
JP4829417B2 (ja) * 2001-03-26 2011-12-07 明夫 乾 インスリン抵抗性改善薬
US20040265381A1 (en) * 2001-10-08 2004-12-30 Shanghvi Dilip S. Anti-asthmatic drug (asmakure) from indigenous herbs to cure the disease asthma
GB0208158D0 (en) * 2002-03-28 2002-05-22 Glaxo Group Ltd Novel compounds
GB0207449D0 (en) * 2002-03-28 2002-05-08 Glaxo Group Ltd Novel compounds
GB0207447D0 (en) * 2002-03-28 2002-05-08 Glaxo Group Ltd Novel compounds
HUP0201980A3 (en) * 2002-06-13 2008-06-30 Richter Gedeon Nyrt Process for preparing a benzamide derivative and intermediates thereof
CN1913876B (zh) * 2003-12-09 2013-06-26 大日本住友制药株式会社 含药物的颗粒和包含这种颗粒的固体制剂
US8524736B2 (en) 2004-01-07 2013-09-03 Armetheon, Inc. Stereoisomeric compounds and methods for the treatment of gastrointestinal and central nervous system disorders
US8138204B2 (en) * 2004-01-07 2012-03-20 Aryx Therapeutics, Inc. Stereoisomeric compounds and methods for the treatment of gastrointestinal and central nervous system disorders
PT2194053E (pt) * 2004-01-07 2013-07-08 Armetheon Inc Derivados de metoxipiperidina para utilização no tratamento de distúrbios gastrointestinais e do sistema nervoso central
TW200619212A (en) 2004-09-08 2006-06-16 Mitsubishi Pharma Corp Morpholine derivatives
WO2007002157A2 (en) 2005-06-23 2007-01-04 Array Biopharma Inc. Process for preparing benzimidazole compounds
DK1919909T3 (da) * 2005-08-31 2013-12-02 Armetheon Inc Syntesemetoder og mellemprodukter for stereoisomere forbindelser, der er anvendelige til behandling af gastrointestinale forstyrrelser og forstyrrelser i centralnervesystemet
WO2007075749A2 (en) * 2005-12-20 2007-07-05 Merck & Co., Inc. Niacin receptor agonists, compositions containing such compounds and methods of treatment
KR100750593B1 (ko) * 2006-03-16 2007-08-20 동우신테크 주식회사 치환된 벤즈아미드 유도체의 제조방법
US20080085915A1 (en) * 2006-06-23 2008-04-10 Cyrus Becker Compounds and methods for the treatment of gastrointestinal and central nervous system disorders
AU2008242703B2 (en) * 2007-04-19 2011-08-18 Concert Pharmaceuticals Inc. Deuterated morpholinyl compounds
CN101402633A (zh) * 2007-09-11 2009-04-08 上海恒瑞医药有限公司 苯甲酰胺类衍生物、其制备方法及其在医药上的用途
JP4989733B2 (ja) 2008-02-13 2012-08-01 大日本住友製薬株式会社 口腔内崩壊錠
TWI423967B (zh) * 2008-02-21 2014-01-21 Dainippon Sumitomo Pharma Co 醯胺衍生物及含有其之醫藥組合物
CN102548542B (zh) 2009-08-11 2013-11-20 大日本住友制药株式会社 含有两种以上粒子的口腔速崩片
WO2011107903A1 (en) 2010-03-04 2011-09-09 Ranbaxy Laboratories Limited Highly pure mosapride citrate dihydrate and processes for its preparation
AU2012221927B2 (en) 2011-02-25 2016-04-28 Yuhan Corporation Diaminopyrimidine derivatives and processes for the preparation thereof
KR101657616B1 (ko) 2013-05-24 2016-09-19 주식회사유한양행 피리미딘 고리를 포함하는 바이사이클릭 유도체 및 그의 제조방법
TWI794171B (zh) 2016-05-11 2023-03-01 美商滬亞生物國際有限公司 Hdac抑制劑與pd-l1抑制劑之組合治療
TWI808055B (zh) 2016-05-11 2023-07-11 美商滬亞生物國際有限公司 Hdac 抑制劑與 pd-1 抑制劑之組合治療
CN111349052B (zh) * 2020-04-07 2021-02-12 福建海西新药创制有限公司 一种枸橼酸莫沙必利的合成方法
CN114560822B (zh) * 2020-11-27 2024-05-28 鲁南制药集团股份有限公司 一种莫沙必利的二羧酸晶体
CN114591260B (zh) * 2020-12-05 2025-07-11 鲁南制药集团股份有限公司 一种莫沙必利有机酸盐
CN119241463A (zh) * 2024-10-22 2025-01-03 吉林修正药业新药开发有限公司 一种枸橼酸莫沙必利杂质化合物及其制备方法
CN119241464A (zh) * 2024-10-22 2025-01-03 吉林修正药业新药开发有限公司 一种枸橼酸莫沙必利杂质化合物及其制备方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH451142A (de) * 1965-01-19 1968-05-15 Sandoz Ag Verfahren zur Herstellung neuer basisch substituierter Benzoesäureamide
US4029786A (en) * 1972-08-11 1977-06-14 Imperial Chemical Industries Limited Morpholine derivatives for treating depression
US4323503A (en) * 1976-08-04 1982-04-06 Societe D'etudes Scientifiques Et Industrielles De L'ile-De-France Substituted 2,3-alkylene di (oxy) benzamides and derivatives
US4210754A (en) * 1977-02-01 1980-07-01 Hoffmann-La Roche Inc. Morpholino containing benzamides
US4692445A (en) * 1983-04-29 1987-09-08 Rorer Pharmaceutical Corporation Bicyclic benzenoid aminoalkylene ethers and thioethers, pharmaceutical compositions and use
FR2575158B1 (fr) * 1984-12-20 1987-10-02 Pf Medicament Arylalcoyloxymethyl-2 morpholines, leur preparation et leur application en tant que medicaments utiles dans le traitement des troubles du systeme nerveux central
JPH0390274A (ja) * 1989-08-28 1991-04-16 Furukawa Alum Co Ltd Al又はAl合金の気相ろう付法

Also Published As

Publication number Publication date
CA1291135C (en) 1991-10-22
PH24049A (en) 1990-03-05
AU592177B2 (en) 1990-01-04
DK218787D0 (da) 1987-04-29
CZ289787A3 (cs) 1998-11-11
DE3781195T2 (de) 1993-02-18
SK279058B6 (sk) 1998-06-03
DK175281B1 (da) 2004-08-09
FI87776B (fi) 1992-11-13
KR870010030A (ko) 1987-11-30
SK289787A3 (en) 1998-06-03
US4870074A (en) 1989-09-26
FI871828A7 (fi) 1987-10-31
DK218787A (da) 1987-10-31
FI871828A0 (fi) 1987-04-27
NZ220120A (en) 1989-06-28
HK18194A (en) 1994-03-11
AU7227587A (en) 1987-11-05
AR242953A1 (es) 1993-06-30
DE3781195D1 (de) 1992-09-24
FI87776C (fi) 1993-02-25
HUT45514A (en) 1988-07-28
EP0243959B1 (en) 1992-08-19
CZ284687B6 (cs) 1999-02-17
EP0243959A1 (en) 1987-11-04
SU1597101A3 (ru) 1990-09-30
ES2043617T3 (es) 1994-01-01
HU198193B (en) 1989-08-28

Similar Documents

Publication Publication Date Title
IN168414B (cg-RX-API-DMAC10.html)
AU7131891A (cg-RX-API-DMAC10.html)
GR3005934T3 (cg-RX-API-DMAC10.html)
IN171245B (cg-RX-API-DMAC10.html)
IN168296B (cg-RX-API-DMAC10.html)
IN169406B (cg-RX-API-DMAC10.html)
IN166628B (cg-RX-API-DMAC10.html)
IN169474B (cg-RX-API-DMAC10.html)
IN169487B (cg-RX-API-DMAC10.html)
CH669517B (cg-RX-API-DMAC10.html)
AU5130385A (cg-RX-API-DMAC10.html)
BE905208A (cg-RX-API-DMAC10.html)
AU5724586A (cg-RX-API-DMAC10.html)
AU4910985A (cg-RX-API-DMAC10.html)
AU5745586A (cg-RX-API-DMAC10.html)
AU5655786A (cg-RX-API-DMAC10.html)
IN167094B (cg-RX-API-DMAC10.html)
IN167019B (cg-RX-API-DMAC10.html)
AU4946385A (cg-RX-API-DMAC10.html)
AU5329886A (cg-RX-API-DMAC10.html)
IN164068B (cg-RX-API-DMAC10.html)
AU4596985A (cg-RX-API-DMAC10.html)
AU5344086A (cg-RX-API-DMAC10.html)
AU5257190A (cg-RX-API-DMAC10.html)
AU5753186A (cg-RX-API-DMAC10.html)